Allergy Therapeutics plc Release: Interim Report for the Six Months Ended 31 December 2012
3/25/2013 10:12:18 AM
More...
|
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens
3/11/2013 12:00:24 PM
More...
|
Allergy Therapeutics plc Preliminary Results for the Year Ended 30 June 2012
9/17/2012 9:59:08 AM
More...
|
Allergy Therapeutics plc: FDA Clinical Hold Lifted
8/3/2012 10:28:01 AM
More...
|
Allergy Therapeutics plc: Notification of Voluntary Product Recall of Anapen® by Lincoln Medical
5/23/2012 11:09:17 AM
More...
|
Allergy Therapeutics plc Release: Anapen® 500mcg Epinephrine Aauto-injector
12/6/2011 8:56:20 AM
More...
|
Allergy Therapeutics plc Release: Submissions of Complete Response to PEI in Germany and Clinical Study Protocol to US FDA
11/28/2011 12:16:01 PM
More...
|
Allergy Therapeutics plc Extends Anapen(C) Distribution Agreement into UK and Ireland
9/19/2011 10:19:04 AM
More...
|
Allergy Therapeutics plc Preliminary Results for the Year Ended 30 June 2011
9/19/2011 10:11:43 AM
More...
|
Allergy Therapeutics plc Enters Latin America in Line With Emerging Market Strategy
8/23/2011 9:38:11 AM
More...
|
|